
NIAID Grants Zepto $8.9 Million to Scale Liquid Biopsy Diagnostics
The National Institute of Allergy and Infectious Diseases has awarded Zepto Life Technology an $8.9 million contract to accelerate the development of its liquid biopsy platform. The funding aims to transition the FungiFlex system from a centralized reference lab model to a deployable diagnostic tool for hospital microbiology units.

























